- Home
- WRBY vs TMDX Comparison
WRBY vs TMDX Comparison
Compare WRBY & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRBY
- TMDX
- Stock Information
- Founded
- WRBY 2010
- TMDX 1998
- Country
- WRBY United States
- TMDX United States
- Employees
- WRBY N/A
- TMDX N/A
- Industry
- WRBY Ophthalmic Goods
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- WRBY Health Care
- TMDX Health Care
- Exchange
- WRBY Nasdaq
- TMDX Nasdaq
- Market Cap
- WRBY 2.1B
- TMDX 2.3B
- IPO Year
- WRBY 2021
- TMDX 2019
- Fundamental
- Price
- WRBY $21.18
- TMDX $127.12
- Analyst Decision
- WRBY Buy
- TMDX Buy
- Analyst Count
- WRBY 15
- TMDX 10
- Target Price
- WRBY $23.33
- TMDX $122.89
- AVG Volume (30 Days)
- WRBY 3.6M
- TMDX 1.2M
- Earning Date
- WRBY 05-08-2025
- TMDX 05-08-2025
- Dividend Yield
- WRBY N/A
- TMDX N/A
- EPS Growth
- WRBY N/A
- TMDX N/A
- EPS
- WRBY N/A
- TMDX 1.41
- Revenue
- WRBY $795,094,000.00
- TMDX $488,227,000.00
- Revenue This Year
- WRBY $15.94
- TMDX $32.58
- Revenue Next Year
- WRBY $13.73
- TMDX $21.65
- P/E Ratio
- WRBY N/A
- TMDX $90.23
- Revenue Growth
- WRBY 13.94
- TMDX 64.43
- 52 Week Low
- WRBY $12.46
- TMDX $55.00
- 52 Week High
- WRBY $28.68
- TMDX $177.37
- Technical
- Relative Strength Index (RSI)
- WRBY 66.39
- TMDX 76.52
- Support Level
- WRBY $19.38
- TMDX $118.79
- Resistance Level
- WRBY $20.90
- TMDX $130.48
- Average True Range (ATR)
- WRBY 1.13
- TMDX 4.49
- MACD
- WRBY 0.32
- TMDX -0.15
- Stochastic Oscillator
- WRBY 80.81
- TMDX 83.53
About WRBY Warby Parker Inc.
Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.